Side effects of rosuvastatin
Pro Research Analysisby 
Searched over 200M research papers
Common Side Effects of Rosuvastatin
Rosuvastatin, a widely used statin for lowering cholesterol, is generally well tolerated but can cause side effects. The most frequently reported side effects include muscle pain (myalgia), muscle cramps, stiffness, and weakness. These symptoms are usually mild and occur less often with rosuvastatin compared to some other statins like atorvastatin, especially in heart transplant patients and the general population 5610. Gastrointestinal issues are also reported but are less common .
Rare and Serious Adverse Reactions
Liver Injury and Hepatitis
Although rare, rosuvastatin can cause serious liver-related side effects, such as drug-induced acute hepatitis. Symptoms may include abdominal pain, nausea, vomiting, fever, and disrupted sleep. These effects typically resolve after stopping the medication, but careful monitoring of liver function is recommended during therapy .
Muscle Toxicity and Rhabdomyolysis
Rosuvastatin can, in rare cases, lead to severe muscle toxicity, including rhabdomyolysis—a potentially life-threatening condition characterized by muscle weakness, myalgia, and dark-colored urine. This risk increases with higher doses and in patients with additional risk factors. Prompt discontinuation of the drug usually leads to recovery 35.
Angioedema
There are rare reports of rosuvastatin causing angioedema, which is swelling of the face, lips, and tongue. This reaction can occur without a rash and may not respond to common allergy medications. Symptoms typically resolve after stopping rosuvastatin .
Pruritus and Dizziness
Some patients may experience pruritus (itching) and dizziness shortly after starting rosuvastatin. These symptoms usually improve or disappear after discontinuing the medication .
Effects on the Liver and Mitochondria
Animal studies show that high doses of rosuvastatin can cause changes in liver cells, including mitochondrial dysfunction and signs of liver tissue adaptation, such as sinusoidal dilation, inflammatory infiltrates, and cell death of hepatocytes. However, doses equivalent to those used in humans do not appear to cause significant liver or mitochondrial damage in animal models 789.
Comparison with Other Statins
Rosuvastatin is associated with a lower prevalence of side effects compared to some other statins, such as atorvastatin. Patients on rosuvastatin tend to have higher medication adherence and better cholesterol reduction, though the cost of therapy may be higher 610.
Conclusion
Rosuvastatin is effective for lowering cholesterol and is generally well tolerated. Most side effects are mild, such as muscle pain and gastrointestinal discomfort. Rare but serious side effects include liver injury, rhabdomyolysis, angioedema, pruritus, and dizziness. Monitoring for these adverse effects is important, especially in patients at higher risk or on higher doses. Overall, rosuvastatin offers a favorable balance of efficacy and safety for most patients.
Sources and full results
Most relevant research papers on this topic
Rosuvastatin-induced acute hepatitis: Insights from clinical experience on drug-induced liver injury
Rosuvastatin can cause drug-induced acute hepatitis, highlighting the importance of diligent monitoring and surveillance to identify and manage potential adverse effects.
Efficacy and severity of side-effects of rosuvastatin compared to other statins post-heart-transplantation
Rosuvastatin effectively lowers cholesterol and triglycerides in heart transplantation patients without additional side-effects, achieving the recommended LDL-target without additional side-effects.
Effects of high rosuvastatin doses on hepatocyte mitochondria of hypercholesterolemic mice
High doses of rosuvastatin can cause premature death in hypercholesterolemic mice, while moderate doses cause morphological and functional alterations in liver mitochondria, but these effects are less severe.
Rosuvastatin: Morphological and Respiratory Effects of High Doses on Liver Mitochondria from Hypercholesterolemic Mice
High doses of rosuvastatin can cause premature death in hypercholesterolemic mice, while moderate doses cause morphological and functional alterations in liver mitochondria, with effects similar to those in human patients intolerant to statins.
DOI